Supplementary Fig. S1. Generation and characterization of the SLFN11-deleted (SLFN11-del) cells in DU145, CCRF-CEM, MOLT4 and EW8 cell lines

A-D. Confirmation of SLFN11 deletion in DU145 (A), CCRF-CEM (B), MOLT4 (C) and EW8 cells (D)
by Western blotting using the indicated antibodies (A-D), and by immunofluorescence using anti-SLFN11 antibody (A and B). Two independent SLFN11-del clones targeted with different sequences by CRISPR/Cas9 system were generated for each cell line [SLFN11-del (A) and SLFN11-del (B)]. Cell cycle and cell growth analyses under normal condition are shown for each cell line (A-D). Percent population of individual cell phases (G1, S and G2) is annotated beside the cell cycle panels. The score is an average of three independent experiments. In the growth curve panels, the relative cell number of parental and SLFN11-del cells are plotted. Error bars represent SD (n ≥ 3). B. Control siRNA (siCtl), SLFN11 siRNA (siSLFN11), and PARP1 siRNA (siPARP1) were transfected into DU145 parental cells. Three days later, expression levels of each protein were analyzed by Western blotting with the indicated antibodies (upper). Two days after transfection, cells were treated with talazoparib or olaparib for an additional 72 hours. Viability was determined as Figure 1C . Error bars represent SD (n = 3).
C. Overexpression of SLFN11 in K562 cells was confirmed by Western blotting with the indicated antibodies (upper). K562 cells overexpressed Flag-tagged wild-type SLFN11 (+SLFN11) and vector only (+Vector) by lentiviral infection were treated with talazoparib (middle) or olaparib (lower) for 72 hours. Viability was determined as Figure 1C . Error bars represent SD (n=3) Supplementary Fig. S3 .
SLFN11-dependent S-phase arrest under talazoparib treatment
The indicated cells were continuously treated with 1 µM talazoparib for 24 hours, and then fixed and stained with propidium iodide (PI). Vertical dashed lines correspond to 2N and 4N DNA contents that are evaluated by PI staining. NT T1 T5  T5+  V1  NT T1  T5  T5+  V1   MOLT4   NT T0.2 T1  T1+  V1  NT T0.2 T1  T1+ 
